Maintenance notice: Some features that submit or update information are temporarily disabled while we migrate the website. You can continue browsing normally. Thank you for your understanding.
Here's what you need to know.
1. The company released its earnings on Aug. 3. It had a $0.27 earnings per share for the quarter, which was significantly lower than Thomson Reuters' $0.35 EPS estimate.
2. Four research analysts gave Entellus a "buy" rating.
3. During the quarter, Entellus earned $18.73 million.
4. Revenue was also up 23.3 percent on a year-over-year basis.
More orthopedic and spinal device news:
Alphatec CFO resigns; company cuts workforce by 20% & more company updates — 5 key points
If you have orthopedic information that you would like to share with the Orthogate Community, please register/login and submit your news, event, job, article, case or workshop from the Submit Content menu under the My Account area. Learn more!
Improving orthopaedic care, education and research using Internet technologies